Mankind Pharma up 6% as PAT rises 29%, margins up 220 bps in Q2FY25

Quick Summary:

As per the filing, the company's growth was partially impacted by regulatory headwinds in certain key products in acute segments and certain initiatives adopted towards field force optimisation to further enhance efficiency.

Mankind Pharma is one of the leading pharmaceutical companies in India, known for its diverse portfolio of medicines and healthcare products.Founded in 1995 by Mr.R.C.

Mankind Pharma declared its September quarter numbers on Tuesday after market hours.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Mankind results Mankind pharma shares Nifty Mankind pharma share price Markets Sensex Bse nse Stock market today

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-06 @ 10:03:56 (2 weeks ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 471 words

Reading Time: 3 minutes read

Sentences: 19 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23441434

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 323 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 7 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions